Cargando…

Organized primary human papillomavirus–based cervical screening: A randomized healthcare policy trial

BACKGROUND: Clinical trials in the research setting have demonstrated that primary human papillomavirus (HPV)-based screening results in greater protection against cervical cancer compared with cytology, but evidence from real-life implementation was missing. To evaluate the effectiveness of HPV-bas...

Descripción completa

Detalles Bibliográficos
Autores principales:	Elfström, K. Miriam, Eklund, Carina, Lamin, Helena, Öhman, Daniel, Hortlund, Maria, Elfgren, Kristina, Sundström, Karin, Dillner, Joakim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8423359/ https://www.ncbi.nlm.nih.gov/pubmed/34424907 http://dx.doi.org/10.1371/journal.pmed.1003748

Ejemplares similares

Randomised healthcare policy evaluation of organised primary human papillomavirus screening of women aged 56–60
por: Lamin, Helena, et al.
Publicado: (2017)

Impact of cervical screening by human papillomavirus genotype: Population-based estimations
por: Wang, Jiangrong, et al.
Publicado: (2023)

Validation of the cobas 6800 human papillomavirus test in primary cervical screening
por: Sundström, Karin, et al.
Publicado: (2021)

Nationwide comprehensive human papillomavirus (HPV) genotyping of invasive cervical cancer
por: Lagheden, Camilla, et al.
Publicado: (2018)

Cervical cancer screening in Sweden 2014-2016
por: Hortlund, Maria, et al.
Publicado: (2018)

High-risk human papillomavirus status and prognosis in invasive cervical cancer: A nationwide cohort study
por: Lei, Jiayao, et al.
Publicado: (2018)

Atypical glandular cells and development of cervical cancer: Population‐based cohort study
por: Norman, Ingrid, et al.
Publicado: (2022)

Effectiveness of cervical screening after age 60 years according to screening history: Nationwide cohort study in Sweden
por: Wang, Jiangrong, et al.
Publicado: (2017)

Deep sequencing detects human papillomavirus (HPV) in cervical cancers negative for HPV by PCR
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2020)

Risk of invasive cervical cancer after atypical glandular cells in cervical screening: nationwide cohort study
por: Wang, Jiangrong, et al.
Publicado: (2016)

Cervical cancer case–control audit: Results from routine evaluation of a nationwide cervical screening program
por: Wang, Jiangrong, et al.
Publicado: (2019)

Human papillomavirus type 16 genomic variation in women with subsequent in situ or invasive cervical cancer: prospective population-based study
por: Arroyo-Mühr, Laila Sara, et al.
Publicado: (2018)

A pilot study of risk-stratified cervical cancer screening
por: Wang, Jiangrong, et al.
Publicado: (2022)

Differing Age-Specific Cervical Cancer Incidence Between Different Types of Human Papillomavirus: Implications for Predicting the Impact of Elimination Programs
por: Vänskä, Simopekka, et al.
Publicado: (2020)

Cervical screening and risk of adenosquamous and rare histological types of invasive cervical carcinoma: population based nested case-control study
por: Andrae, Bengt, et al.
Publicado: (2019)

Impact of HPV vaccination on cervical screening performance: a population-based cohort study
por: Lei, Jiayao, et al.
Publicado: (2020)

Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Human papillomavirus genotype-specific risks for cervical intraepithelial lesions
por: Nygård, Mari, et al.
Publicado: (2020)

Long term duration of protective effect for HPV negative women: follow-up of primary HPV screening randomised controlled trial
por: Elfström, K Miriam, et al.
Publicado: (2014)

Advances in cervical cancer prevention: Efficacy, effectiveness, elimination?
por: Sundström, Karin, et al.
Publicado: (2020)

Expressed Prostate Secretions in the Study of Human Papillomavirus Epidemiology in the Male
por: Smelov, Vitaly, et al.
Publicado: (2013)

Lack of Significant Effects of Chlamydia trachomatis Infection on Cervical Adenocarcinoma Risk: Nested Case-Control Study
por: Smelov, Vitaly, et al.
Publicado: (2016)

Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme
por: Nygård, Mari, et al.
Publicado: (2014)

Targeting Human Papillomavirus to Reduce the Burden of Cervical, Vulvar and Vaginal Cancer and Pre-Invasive Neoplasia: Establishing the Baseline for Surveillance
por: Nygård, Mari, et al.
Publicado: (2014)

Quality assurance in human papillomavirus testing for primary cervical screening
por: Cuschieri, Kate, et al.
Publicado: (2023)

Human papillomavirus types in cervical high‐grade lesions or cancer among Nordic women—Potential for prevention
por: Dovey de la Cour, Cecilie, et al.
Publicado: (2019)

High-grade cervical intraepithelial neoplasia in human papillomavirus self-sampling of screening non-attenders
por: Lam, J U H, et al.
Publicado: (2018)

Potential SARS-CoV-2 infectiousness among asymptomatic healthcare workers
por: Pimenoff, Ville N., et al.
Publicado: (2021)

Clinical validation of full genotyping CLART® HPV4S assay on SurePath and ThinPrep collected screening samples according to the international guidelines for human papillomavirus test requirements for cervical screening
por: Ejegod, Ditte Møller, et al.
Publicado: (2020)

Type-Specific Human Papillomavirus Biological Features: Validated Model-Based Estimates
por: Baussano, Iacopo, et al.
Publicado: (2013)

Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years
por: Östensson, Ellinor, et al.
Publicado: (2015)

Correction: Barriers to and Facilitators of Compliance with Clinic-Based Cervical Cancer Screening: Population-Based Cohort Study of Women Aged 23-60 Years
por: Östensson, Ellinor, et al.
Publicado: (2015)

The Participation of HPV-Vaccinated Women in a National Cervical Screening Program: Population-Based Cohort Study
por: Herweijer, Eva, et al.
Publicado: (2015)

Head-to-Head Comparison of Bi- and Nonavalent Human Papillomavirus Vaccine-Induced Antibody Responses( )
por: Arroyo Mühr, Laila Sara, et al.
Publicado: (2022)

Estimating total excess mortality during a COVID-19 outbreak in Stockholm, Sweden
por: Pimenoff, Ville N, et al.
Publicado: (2020)

Predicting past and future SARS-CoV-2-related sick leave using discrete time Markov modelling
por: Lei, Jiayao, et al.
Publicado: (2022)

The WID-CIN test identifies women with, and at risk of, cervical intraepithelial neoplasia grade 3 and invasive cervical cancer
por: Barrett, James E., et al.
Publicado: (2022)

The Launch of an International Animal Papillomavirus Reference Center
por: Van Doorslaer, Koenraad, et al.
Publicado: (2019)

Minor Cytological Abnormalities and up to 7-Year Risk for Subsequent High-Grade Lesions by HPV Type
por: Persson, Maria, et al.
Publicado: (2015)

Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model
por: de Kok, Inge M C M, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_7j9dvo59fh92ksa9l6s54b0h43